Literature DB >> 24664312

Is a complete blood cell count useful in determining the prognosis of pulmonary embolism?

Hadice Selimoglu Sen1, Ozlem Abakay, Abdullah Cetin Tanrikulu, Cengizhan Sezgi, Mahsuk Taylan, Abdurrahman Abakay, Halide Kaya, Abdurrahman Senyigit.   

Abstract

BACKGROUND: Pulmonary embolism (PE) is the third cardiovascular cause of hospital admission, following acute coronary syndrome and stroke. Despite high-tech diagnostic methods and new treatment modalities, PEs continue to have a high mortality rate within the first 3 months. This study was designed to assess the additional prognostic value of a complete blood cell count, renal function markers, C-reactive protein, and simplified pulmonary embolism severity index (sPESI) scoring system in PE 100-day mortality.
MATERIALS AND METHODS: The study retrospectively enrolled 208 consecutive patients who were hospitalized with the diagnosis of an acute PE. The patients' demographic characteristics and clinical and laboratory parameters were recorded from the hospital electronic database and patient's case notes. The primary end point of the study was an adverse 100-day outcome, defined as death from any cause.
RESULTS: The all-cause mortality in the first 100 days was 14.42 %. The mean age was 57.87 ± 18.17 (range: 16-93) years. We included 79 (38 %) male and 129 (62 %) female individuals. Red cell distribution width (RDW) and sPESI were found to be statistically significant predictors of PE mortality by multivariate regression analysis. On multivariate regression analysis, RDW was associated with a 4.08-fold (95 % confidence interval: 1.229-13.335, P = 0.021) increase in PE mortality.
CONCLUSION: The results of this study demonstrated that RDW and sPESI may be a useful guide in predicting 100-day mortality. The elevated RDW may alert physicians to possible poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24664312     DOI: 10.1007/s00508-014-0537-1

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  39 in total

1.  Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.

Authors:  D W BARRITT; S C JORDAN
Journal:  Lancet       Date:  1960-06-18       Impact factor: 79.321

2.  Which white blood cell subtypes predict increased cardiovascular risk?

Authors:  Benjamin D Horne; Jeffrey L Anderson; Jerry M John; Aaron Weaver; Tami L Bair; Kurt R Jensen; Dale G Renlund; Joseph B Muhlestein
Journal:  J Am Coll Cardiol       Date:  2005-04-25       Impact factor: 24.094

3.  Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity.

Authors:  M Onsrud; E Thorsby
Journal:  Scand J Immunol       Date:  1981       Impact factor: 3.487

4.  Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.

Authors:  Karen L Margolis; JoAnn E Manson; Philip Greenland; Rebecca J Rodabough; Paul F Bray; Monika Safford; Richard H Grimm; Barbara V Howard; Annlouise R Assaf; Ross Prentice
Journal:  Arch Intern Med       Date:  2005-03-14

5.  C-reactive protein in acute pulmonary embolism.

Authors:  Yasin Abul; Sait Karakurt; Beste Ozben; Ahmet Toprak; Turgay Celikel
Journal:  J Investig Med       Date:  2011-01       Impact factor: 2.895

6.  Derivation and validation of a prognostic model for pulmonary embolism.

Authors:  Drahomir Aujesky; D Scott Obrosky; Roslyn A Stone; Thomas E Auble; Arnaud Perrier; Jacques Cornuz; Pierre-Marie Roy; Michael J Fine
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

7.  The automated complete blood cell count. Use of the red blood cell volume distribution width and mean platelet volume in evaluating anemia and thrombocytopenia.

Authors:  A Karnad; T R Poskitt
Journal:  Arch Intern Med       Date:  1985-07

8.  Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry.

Authors:  Silvy Laporte; Patrick Mismetti; Hervé Décousus; Fernando Uresandi; Remedios Otero; Jose Luis Lobo; Manuel Monreal
Journal:  Circulation       Date:  2008-03-17       Impact factor: 29.690

9.  Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Clive Kearon; Susan R Kahn; Giancarlo Agnelli; Samuel Goldhaber; Gary E Raskob; Anthony J Comerota
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

10.  Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

Authors:  Adam Torbicki; Arnaud Perrier; Stavros Konstantinides; Giancarlo Agnelli; Nazzareno Galiè; Piotr Pruszczyk; Frank Bengel; Adrian J B Brady; Daniel Ferreira; Uwe Janssens; Walter Klepetko; Eckhard Mayer; Martine Remy-Jardin; Jean-Pierre Bassand
Journal:  Eur Heart J       Date:  2008-08-30       Impact factor: 29.983

View more
  9 in total

Review 1.  A narrative review of red blood cell distribution width as a marker for pulmonary embolism.

Authors:  Lindsay Hammons; Jason Filopei; David Steiger; Eric Bondarsky
Journal:  J Thromb Thrombolysis       Date:  2019-11       Impact factor: 2.300

2.  Red cell distribution width: a novel prognostic factor of pulmonary embolism?

Authors:  Ergenekon Karagöz; Mehmet Doğan; Alpaslan Tanoglu
Journal:  Wien Klin Wochenschr       Date:  2014-11-01       Impact factor: 1.704

3.  Red cell distribution width in pulmonary embolism.

Authors:  Sevket Balta; Ibrahim Karademir; Mustafa Demir; Cengiz Ozturk; Turgay Celik; Sait Demirkol
Journal:  Wien Klin Wochenschr       Date:  2014-07-22       Impact factor: 1.704

4.  Red cell distribution width: a novel predictor of mortality in critically ill patients.

Authors:  Libing Jiang; Xia Feng; Yuefeng Ma; Mao Zhang
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

5.  Red Cell Distribution Width and Mortality in Hemodialysis Patients.

Authors:  Tania Vashistha; Elani Streja; Miklos Z Molnar; Connie M Rhee; Hamid Moradi; Melissa Soohoo; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2016-01-16       Impact factor: 8.860

6.  Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality.

Authors:  Julia Riedl; Florian Posch; Oliver Königsbrügge; Felix Lötsch; Eva-Maria Reitter; Ernst Eigenbauer; Christine Marosi; Ilse Schwarzinger; Christoph Zielinski; Ingrid Pabinger; Cihan Ay
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

Review 7.  Prognostic Value of Red Blood Cell Distribution Width in Non-Cardiovascular Critically or Acutely Patients: A Systematic Review.

Authors:  Rubin Luo; Jian Hu; Libing Jiang; Mao Zhang
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 8.  Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis.

Authors:  Antoine Elias; Susan Mallett; Marie Daoud-Elias; Jean-Noël Poggi; Mike Clarke
Journal:  BMJ Open       Date:  2016-04-29       Impact factor: 2.692

9.  Association of mean platelet volume and red blood cell distribution width with coronary collateral development in stable coronary artery disease.

Authors:  Isa Sincer; Yilmaz Gunes; Asli Kurtar Mansiroglu; Mehmet Cosgun; Gulali Aktas
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-09-21       Impact factor: 1.426

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.